The weekly litigation news digest is live. Subscribe now

IP Verse

Methods And Medicament For Inhibition The Expression Of A Defined Gene - EP1798285

The patent EP1798285 was granted to Alnylam Europe on Mar 15, 2017. The application was filed on Jan 29, 2000 under application number EP06025389A. The patent is currently recorded with a legal status of "Revoked".

EP1798285

ALNYLAM EUROPE
Application Number
EP06025389A
Filing Date
Jan 29, 2000
Status
Revoked
Jun 28, 2019
Publication Date
Mar 15, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SILENCE THERAPEUTICSDec 15, 2017CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO0136646
OPPOSITIONEP1798285
OPPOSITIONWO0044914
OPPOSITIONWO2004015107
OPPOSITIONWO9932619
SEARCHWO0063364
SEARCHWO9219732
SEARCHWO9805770
SEARCHWO9932619
SEARCHWO9949029
SEARCHWO9953050
SEARCHWO9961631

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents